No Data
No Data
Express News | AVROBIO Shareholders Approved Effecting Reverse Split At Ration In Range Of 1:3 And 1:30
Express News | AVROBIO - on June 11, Co's Stockholders Approved Effecting Reverse Stock Split of Avro's Issued Common Stock at a Ratio in Range Between 1:3 & 1:30
Tectonic Therapeutic Appoints Daniel Lochner as Chief Financial Officer
Tectonic Therapeutic, Inc. ("Tectonic"), a privately-held biotechnology company developing GPCR (G-protein coupled receptor)-targeted therapeutic proteins, today announced the appointment of Daniel Lochner as Chief
Avrobio(AVRO.US) 10% Shareholder Buys US$971.49K in Common Stock
$Avrobio(AVRO.US)$ 10% Shareholder Leonard Braden Michael purchased 766.64K shares of common stock on May 13, 14, 2024 at an average price of $1.267 for a total value of $971.49K.Source: Announcement
Avrobio Insider Bought Shares Worth $971,493, According to a Recent SEC Filing
Braden Michael Leonard, 10% Owner, on May 13, 2024, executed a purchase for 766,635 shares in Avrobio (AVRO) for $971,493. Following the Form 4 filing with the SEC, Leonard has control over a total of
AVROBIO's Pivot and Tectonic Merger: Navigating the New Complex Regulatory Terrain
No Data
TrytosaveabitOP : Upon Completion of Merger, Combined Co Expected to Operate Under the Name Tectonic Therapeutic and Trade on Nasdaq Under Ticker Symbol